Market Cap | 45.77B | P/E | 35.67 | EPS this Y | -12.40% | Ern Qtrly Grth | -36.90% |
Income | 1.49B | Forward P/E | 18.97 | EPS next Y | 8.80% | 50D Avg Chg | -6.00% |
Sales | 15.49B | PEG | 12.23 | EPS past 5Y | - | 200D Avg Chg | -7.00% |
Dividend | N/A | Price/Book | 2.26 | EPS next 5Y | 1.49% | 52W High Chg | -14.00% |
Recommedations | 2.50 | Quick Ratio | 0.54 | Shares Outstanding | 1.91B | 52W Low Chg | 6.00% |
Insider Own | 0.02% | ROA | 5.91% | Shares Float | 1.73B | Beta | - |
Inst Own | 99.67% | ROE | 9.65% | Shares Shorted/Prior | 27.80M/34.60M | Price | 23.90 |
Gross Margin | 56.57% | Profit Margin | 9.63% | Avg. Volume | 6,846,304 | Target Price | 22.40 |
Oper. Margin | 17.00% | Earnings Date | - | Volume | 15,999,131 | Change | 1.06% |
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
HSBC | Hold | May 8, 24 |
Bernstein | Underperform | Apr 11, 24 |
William Blair | Market Perform | Apr 3, 24 |
Goldman Sachs | Neutral | Mar 4, 24 |
Goldman Sachs | Neutral | Mar 1, 24 |
RBC Capital | Outperform | Feb 13, 24 |
JP Morgan | Overweight | Feb 9, 24 |
RBC Capital | Outperform | Feb 9, 24 |
UBS | Neutral | Dec 19, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
ALLISON RICHARD E JR | Director Director | Aug 30 | Buy | 22.9589 | 5,598 | 128,524 | 25,598 | 08/31/23 |